GoodRx to offer Sanofi insulin injection Lantus for only USD 35 in US
Advertisement
United States: GoodRx has said it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its digital marketplace in the U.S.
All Americans, regardless of insurance status, on prescriptions can buy a 30-day supply of the diabetes drug at a much lower price using a coupon on the company's digital healthcare platform, GoodRx said.
This collaboration comes after Novo Nordisk, Eli Lilly and Sanofi pledged in March to lower the list prices of many of their insulin products by 70%-78% later in the year or in 2024.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.